Fundación Lindavista del Corazón AC Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2008
NCT00738972
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertrophy (Phase 3)

Hypertrophy, Left Ventricular (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 4